{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:24:49Z","timestamp":1778552689649,"version":"3.51.4"},"reference-count":0,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"vor","delay-in-days":2433,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1997,3]]},"abstract":"<jats:p>OBJECTIVE\u2003The outlook for fertility and attaining full adult height is poor in women with congenital adrenal hyperplasia. Such outcomes have followed treatment regimes with variable ages at onset, compliance rates and monitoring. We review final height, vaginal anatomy, ovulation rates and fertility in a group of adult females with the disease.<\/jats:p><jats:p>DESIGN AND PATIENTS\u2003Sixteen adult females first diagnosed in infancy or early childhood were reviewed (age range 17\u201333 years; 11 with salt\u2010wasting disease; five with simple virilizing disease). Case note and clinical review were combined with daily saliva progesterone and weekend 17\u2010hydroxyprogesterone estimation in three consecutive menstrual cycles in a subgroup of eight patients in the ovulation study.<\/jats:p><jats:p>MEASUREMENTS AND ANALYSIS\u2003Daily saliva progesterone concentrations were transformed into a cumulative sum curve using a computer program. <jats:italic>T<\/jats:italic><jats:sub>95<\/jats:sub> (defined as the number of days from the start of the luteal phase saliva progesterone rise, in which 95% of total saliva progesterone for the menstrual cycle was obtained) and log <jats:italic>C<\/jats:italic><jats:sub>95<\/jats:sub> (where <jats:italic>C<\/jats:italic><jats:sub>95<\/jats:sub> was defined as 95% of total saliva progesterone for the same cycle) were plotted for each cycle on a boundary diagram obtained from a normal reference population. Weekend saliva 17\u2010hydroxyprogesterone concentrations were compared with published nomograms.<\/jats:p><jats:p>RESULTS\u2003The majority of patients attained a final height below the parental target. Mean standard deviation scores (\u00b1SEM) and ranges were \u22121.49 (\u00b10.34) and \u22124.2 to 0.8 for the patients and \u22120.38 (\u00b10.24) and \u22121.89 to 0.97 for their parents. Of the combined group two\u2010thirds had regular menses and one\u2010third hirsutism; 94% had reconstructive genital surgery with 50% requiring second procedures; 77% had an adequate vaginal introitus (of them 84% in the salt\u2010wasting group and 75% in the simple virilizing group were sexually active). Three of five patients with salt\u2010wasting disease and 2\/3 with simple virilizing disease who had both an adequate introitus and were sexually active conceived, resulting in eight pregnancies. In the ovulation study, a 40% ovulation rate was observed with good correlation between plasma testosterone concentrations and degree of control as assessed by weekend 17\u2010hydroxyprogesterone concentrations.<\/jats:p><jats:p>CONCLUSIONS\u2003Our study highlights the potential for improved fertility in female patients with congenital adrenal hyperplasia, who are treated early, comply with long\u2010term treatment and have adequately reconstructed external genitalia. Attaining full adult height potential remains a problem.<\/jats:p>","DOI":"10.1046\/j.1365-2265.1997.1360962.x","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T20:05:51Z","timestamp":1068235551000},"page":"327-332","source":"Crossref","is-referenced-by-count":100,"title":["Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience"],"prefix":"10.1111","volume":"46","author":[{"given":"L. D. K. E.","family":"Premawardhana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. F.","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Scanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,29]]},"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1997.1360962.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1997.1360962.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1997.1360962.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:41:17Z","timestamp":1698403277000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1997.1360962.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1046\/j.1365-2265.1997.1360962.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1997.1360962.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}